Cancer Treatment Reviews
Volume 31 , Pages S17-S25 , 2005

Case studies of fulvestrant (‘Faslodex’) in postmenopausal women with advanced breast cancer

  • Paul Abram

      Affiliations

    • Belvoir Park Hospital, Hospital Road, Belfast, Northern Ireland, UK
    • Corresponding Author InformationCorresponding author. Tel.: + 44 2890 699 323; fax: + 44 2890 699 406.
    • ,
  • Nicolai Maass

      Affiliations

    • University of Kiel, Kiel, Germany
    • ,
  • Daniel Rea

      Affiliations

    • QEII Hospital, Birmingham, UK
    • ,
  • Sergio D. Simon

      Affiliations

    • Hospital Albert Einstein, São Paulo, Brazil
    • ,
  • Guenther G. Steger

      Affiliations

    • University of Vienna, Vienna, Austria

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00142-8

doi: 10.1016/j.ctrv.2005.08.008

Cancer Treatment Reviews
Volume 31 , Pages S17-S25 , 2005

Article Tools

* Image Usage & Resolution